Invest Now
Samco Star Rating Ads

Procter Gamble Health Ltd Price Performance

  • Day's Low
  • ₹5,494.15
  • Day's High
  • ₹5,742.40
₹ 5,544.05
  • 52-w low
  • ₹4,636.55
  • 52-w high
  • ₹5,742.40
5,544.05
  • Day's open
    ₹5,583.95
  • Previous close
    ₹5,287
  • VWAP
    ₹5,637.16
  • Lower price band
    ₹4,229.60
  • Upper price band
    ₹6,344.40

Today's Market Action

The last traded share price of Procter Gamble Health Ltd was 5,544.05 up by 4.86% on the NSE. Its last traded stock price on BSE was 5,599 up by 6.06%. The total volume of shares on NSE and BSE combined was 132,201 shares. Its total combined turnover was Rs 74.52 crores.

Procter Gamble Health Ltd Medium and Long Term Market Action

Procter Gamble Health Ltd hit a 52-week high of 5,742.40 on 05-11-2024 and a 52-week low of 4,636.55 on 25-04-2024. The stock price of Procter Gamble Health Ltd is up by 5% over the last one month. It is up by 7.86% over the last one year. Don't forget to check the full stock price history in the table below.

Procter Gamble Health Ltd Fundamentals

  • Market Cap (Cr): 8776

  • Book Value (₹):

  • Stock P/E:

  • Revenue (Cr):

  • Total Debt (Cr):

  • Face Value (₹):

  • Roce (%):

  • ROE (%):

  • Earnings (Cr):

  • Promoter’s Holdings (%):

  • EPS (₹):

  • Debt to Equity:

  • Dividend Yield (%):

  • Cash (Cr):

Procter Gamble Health Ltd Mutual fund holdings and trends

FUND NAME Quantity Monthly Change (Qty)

Procter Gamble Health Ltd Shareholding Pattern

Similar Stocks

Company Price Market Cap (Cr) P/E

About Procter Gamble Health Ltd

Data not available.

Procter Gamble Health Ltd FAQ's

What is Share Price of Procter Gamble Health Ltd?

What is the Market Cap of Procter Gamble Health Ltd?

What is PE Ratio of Procter Gamble Health Ltd?

What is PB Ratio of Procter Gamble Health Ltd?

What is the CAGR of Procter Gamble Health Ltd?

How to Buy Procter Gamble Health Ltd Share?

Financials

(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

  • Above Average Sustainable RoE
    The company generates a sustainable return on equity greater than the expected cost of capital which implies that the underlying business can create and compound value over a period time due to it's ability to generate above average return on capital.
  • High Pricing Power
    The business enjoys a relatively high pricing power and is able to withstand competitive pressure which works as a great moat for equity shareholders of the company.
  • Asset Light Business
    The company operates a great asset light business with a high Asset turnover ratio of 9.23. A high asset turnover ratio is a great driver of RoE and can improve shareholder returns. A relatively higher asset turnover ratio also will result in lower dilution as the business grows its revenues as earnings.
  • Zero Debt
    The company has almost nil to negligible debt to equity ratio of 0.02. Considering the fact that the business is debt free, equity shareholders shall carry lower risk of holding the stock.

Cons

  • Momentum Strength
    The stock is currently exhibiting weak momentum, & is showing weak relative strength.
  • Poor Cash Flow Conversion
    The business has very poor cash conversion ratio of only 0.00% of operating earnings getting converted into operating cash flow. This implies that increase in profits has not translated into higher cash flows for the business and incrementally higher investments in working capital which works negatively for shareholders.
  • Highly Cyclical Industry
    The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
  • Poor Capital Allocation
    The company has disproportionately high amount of assets locked up in working capital, cash and cash equivalents, loans and advances, etc to the extent of 83.12 % of total assets. This reflects poorly on the capital allocation strategy of the management which negatively impacts shareholder returns.

Valuation Analysis

Margin of safety
(05/11/2024)
Stock Valuation
Green line
98
100.00%
100.00% People are bullish about Procter Gamble Health Ltd
0.00%
0.00 % People are bearish about Procter Gamble Health Ltd

What is your opinion about this Stock?

Historical Data

Samco Star Rating Ads

Procter Gamble Health Ltd

5,544.05 +257.05 (4.86%)

Brokerage & Taxes at Samco

Brokerage & Taxes at Other traditional broker

Potential Brokerage Savings with Samco ₹ 49.62()

Top Gainers (NIFTY 50)

Stock Name Change %

    Top Losers (NIFTY 50)

    Stock Name Change %

      Open Free Account Now
      Open a Demat Account

      Free Trading & Demat Account

      +91